294 related articles for article (PubMed ID: 19050385)
1. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.
Crum-Cianflone N; Hullsiek KH; Marconi V; Weintrob A; Ganesan A; Barthel RV; Fraser S; Agan BK; Wegner S
AIDS; 2009 Jan; 23(1):41-50. PubMed ID: 19050385
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous malignancies among HIV-infected persons.
Crum-Cianflone N; Hullsiek KH; Satter E; Marconi V; Weintrob A; Ganesan A; Barthel RV; Fraser S; Agan BK
Arch Intern Med; 2009 Jun; 169(12):1130-8. PubMed ID: 19546414
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
4. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
5. HIV infection and the risk of cancers with and without a known infectious cause.
Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP; Towner WJ; Abrams DI
AIDS; 2009 Nov; 23(17):2337-45. PubMed ID: 19741479
[TBL] [Abstract][Full Text] [Related]
6. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
7. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.
Crum-Cianflone NF; Hullsiek KH; Marconi VC; Ganesan A; Weintrob A; Barthel RV; Agan BK;
AIDS; 2010 Feb; 24(4):535-43. PubMed ID: 19926961
[TBL] [Abstract][Full Text] [Related]
8. Malignancies in HIV: pre- and post-highly active antiretroviral therapy.
Nutankalva L; Wutoh AK; McNeil J; Frederick WR; Reddy RB; Daftary M; Gentles A; Addae-Afoakwa K
J Natl Med Assoc; 2008 Jul; 100(7):817-20. PubMed ID: 18672558
[TBL] [Abstract][Full Text] [Related]
9. [Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].
Jabłonowska E; Małolepsza E; Strycharz M; Wójcik K
Przegl Epidemiol; 2011; 65(2):339-43. PubMed ID: 21913486
[TBL] [Abstract][Full Text] [Related]
10. Virologic and Immunologic Outcomes in HIV-Infected Patients with Cancer.
Riedel DJ; Stafford KA; Vadlamani A; Redfield RR
AIDS Res Hum Retroviruses; 2017 May; 33(5):482-489. PubMed ID: 27824263
[TBL] [Abstract][Full Text] [Related]
11. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
12. Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.
Chao C; Leyden WA; Xu L; Horberg MA; Klein D; Towner WJ; Quesenberry CP; Abrams DI; Silverberg MJ
AIDS; 2012 Nov; 26(17):2223-31. PubMed ID: 22951631
[TBL] [Abstract][Full Text] [Related]
13. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
[TBL] [Abstract][Full Text] [Related]
14. Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico.
Cornejo-Juárez P; Cavildo-Jerónimo D; Volkow-Fernández P
AIDS Res Ther; 2018 Oct; 15(1):16. PubMed ID: 30368240
[TBL] [Abstract][Full Text] [Related]
15. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors.
Petoumenos K; Hui E; Kumarasamy N; Kerr SJ; Choi JY; Chen YM; Merati T; Zhang F; Lim PL; Sungkanuparph S; Pujari S; Ponnampalavanar S; Ditangco R; Lee CK; Grulich A; Law MG;
J Int AIDS Soc; 2010 Dec; 13():51. PubMed ID: 21143940
[TBL] [Abstract][Full Text] [Related]
16. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.
Bedimo RJ; McGinnis KA; Dunlap M; Rodriguez-Barradas MC; Justice AC
J Acquir Immune Defic Syndr; 2009 Oct; 52(2):203-8. PubMed ID: 19617846
[TBL] [Abstract][Full Text] [Related]
17. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
Achenbach CJ; Cole SR; Kitahata MM; Casper C; Willig JH; Mugavero MJ; Saag MS
AIDS; 2011 Mar; 25(5):691-700. PubMed ID: 21160411
[TBL] [Abstract][Full Text] [Related]
18. Retrospective cohort study of cancer incidence and mortality by HIV status in a Georgia, USA, prisoner cohort during the HAART era.
Zlotorzynska M; Spaulding AC; Messina LC; Coker D; Ward K; Easley K; Baillargeon J; Mink PJ; Simard EP
BMJ Open; 2016 Apr; 6(4):e009778. PubMed ID: 27067888
[TBL] [Abstract][Full Text] [Related]
19. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
[TBL] [Abstract][Full Text] [Related]
20. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
